Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Income (2016 - 2025)

Historic Net Income for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $46.7 million.

  • Prestige Consumer Healthcare's Net Income fell 2348.93% to $46.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $186.5 million, marking a year-over-year decrease of 1282.35%. This contributed to the annual value of $214.6 million for FY2025, which is 251.55% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Net Income of $46.7 million as of Q4 2025, which was down 2348.93% from $42.2 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Net Income registered a high of $61.0 million during Q4 2024, and its lowest value of -$240.6 million during Q1 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's median Net Income value was $50.6 million (recorded in 2021), while the average stood at $35.9 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Net Income crashed by 56183.62% in 2023 and then surged by 12056.02% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Net Income (Quarter) stood at $50.2 million in 2021, then increased by 3.46% to $52.0 million in 2022, then grew by 2.11% to $53.0 million in 2023, then grew by 15.05% to $61.0 million in 2024, then decreased by 23.49% to $46.7 million in 2025.
  • Its Net Income stands at $46.7 million for Q4 2025, versus $42.2 million for Q3 2025 and $47.5 million for Q2 2025.